The short answer
Ginger powder has improved average glucose measures in a small trial, but this does not establish extra hypoglycemia with glipizide. The exact combination remains uncertain.
What this answer covers
Dried Zingiber officinale rhizome powder, commonly called root powder; not isolated gingerols, essential oil or all extracts.
- Supplement or preparation
- Zingiber Officinale (Ginger) Root Powder
- Medication ingredient
- glipizide
A powder trial measured average glucose control
An eight-week trial in type 2 diabetes tested ginger powder capsules and found lower fasting glucose and HbA1c measures. The study concerns powder, which is closer to this ingredient than an isolated ginger chemical.
It did not establish a glipizide adverse effect
The inspected abstract does not identify a glipizide-specific treatment group or provide a hypoglycemia event analysis. Better average glucose control is not the same outcome as clinically low glucose.
Do not turn the trial dose into a safety threshold
The amount and duration studied cannot define a safe dose with glipizide. Other preparations and multi-ingredient glucose products may behave differently, and ordinary culinary ginger is not equivalent to a supplement regimen.
Review changes and symptoms
Discuss the exact product and amount with the diabetes team before starting or changing it. Follow your established glucose-monitoring and low-glucose treatment plan; do not adjust glipizide yourself. Do not assume a short gap between doses prevents a glucose effect, and do not replace prescribed treatment with ginger.
Evidence and practical considerations
Side effects & toxicity
Powder trial supports glucose-efficacy signal but supplies no exact glipizide co-use or hypoglycemia outcomes.
- Exact scope
- Dried Zingiber officinale rhizome powder, commonly called root powder; not isolated gingerols, essential oil or all extracts. with Oral glipizide RxCUI4821 IN, immediate and extended release distinguished.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- Exact source preparation, medication and endpoint limits apply; no universal dose change or spacing.
Factors that may matter: Formulation; Dose and duration; Meal pattern; Other glucose-lowering agents; Kidney and liver function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients with type 2 diabetes receiving glipizide.
Glipizide can cause severe hypoglycemia; added glucose-lowering agents warrant observation. Nicotinic acid can worsen glycemic control; withdrawal also needs observation.
How this applies: Exact glipizide formulation and supplement preparation matter; other sulfonylureas and glucose efficacy endpoints are not automatically glipizide hypoglycemia evidence.
Separate formulations and meal instructions; no automatic transfer of immediate-release antacid pharmacokinetics to XL. Does not establish a risk rate for these herbs.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients with type 2 diabetes receiving glipizide.
Glipizide can cause severe hypoglycemia; added glucose-lowering agents warrant observation. Nicotinic acid can worsen glycemic control; withdrawal also needs observation.
How this applies: Exact glipizide formulation and supplement preparation matter; other sulfonylureas and glucose efficacy endpoints are not automatically glipizide hypoglycemia evidence.
Separate formulations and meal instructions; no automatic transfer of immediate-release antacid pharmacokinetics to XL. Does not establish a risk rate for these herbs.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 88participants with type 2 diabetes.
Ginger powder reduced fasting glucose and HbA1c measures relative to the study comparison; hypoglycemia rates not supplied.
How this applies: Exact glipizide formulation and supplement preparation matter; other sulfonylureas and glucose efficacy endpoints are not automatically glipizide hypoglycemia evidence.
No glipizide-specific regimen or low-glucose adverse-event analysis in inspected abstract. Glucose improvement is not necessarily hypoglycemia.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact glipizide article preserving formulation, preparation and glucose endpoint distinctions. | |
| Research summary published |
Article revision: 35585927f86cc505
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.